A novel small-molecule antagonizes PRMT5-mediated KLF4 methylation for targeted therapy

BACKGROUND: Triple negative breast cancers (TNBCs) have a poor prognosis and are not amenable to endocrine- or HER2-targeted therapies. The malignant and invasive feature of TNBCs is correlated with its high cancer stem cell population. Recent results from us and others have unveiled an oncogenic ro...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:EBioMedicine
Autors principals: Zhou, Zhuan, Feng, Zhiwei, Hu, Dong, Yang, Peng, Gur, Mert, Bahar, Ivet, Cristofanilli, Massimo, Gradishar, William J., Xie, Xiang-qun, Wan, Yong
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2019
Matèries:
Research paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6604046/
https://ncbi.nlm.nih.gov/pubmed/31101597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2019.05.011
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars